Dr. Durmowicz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Food and Drug Administration,
10903 New Hampshire Ave. Building 22, Room 3318
Silver Spring, MD 20993Phone+1 301-796-1965- Is this information wrong?
Education & Training
- University of ColoradoFellowship, Pediatric Critical Care Medicine, 1990 - 1991
- University of ColoradoFellowship, Pediatric Pulmonology, 1987 - 1990
- University of ColoradoResidency, Pediatrics, 1983 - 1986
- University of Maryland School of MedicineClass of 1983
Certifications & Licensure
- MD State Medical License 1986 - 2018
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 25 citationsBuilding global development strategies for cf therapeutics during a transitional cftr modulator eraNicole Mayer-Hamblett, S. van Koningsbruggen-Rietschel, Dave P. Nichols, Donald R. VanDevanter, Jane C. Davies, Tim W.R. Lee, Anthony G. Durmowicz, Felix Ratjen, Micha...> ;Journal of Cystic Fibrosis. 2020 Jun 7
- 31 citationsDeveloping Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities.Dave P. Nichols, Anthony G. Durmowicz, Ann Field, Patrick A. Flume, Donald R. VanDevanter, Nicole Mayer-Hamblett> ;Annals of the American Thoracic Society. 2019 May 1
- 164 citations“CFTR Modulator Theratyping: Current Status, Gaps and Future Directions”John P. Clancy, Calvin U. Cotton, Scott H. Donaldson, George M. Solomon, Donald R. VanDevanter, Michael P. Boyle, Martina Gentzsch, Jerry A. Nick, Beate Illek, John C....> ;Journal of Cystic Fibrosis. 2019 Jan 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: